NPORT-EX 1 T.RowePriceValueFund.htm val33119quarterly_draft2.htm - Generated by SEC Publisher for SEC Filing

T. ROWE PRICE VALUE FUND
March 31, 2019 (Unaudited)

Portfolio of Investments  Shares/Par  $ Value 
(Cost and value in $000s)     
COMMON STOCKS 98.3%     
COMMUNICATION SERVICES 4.6%     
Diversified Telecommunication Services 2.7%     
AT&T  112,654  3,533 
Verizon Communications  11,053,437  653,589 
    657,122 
Entertainment 0.3%     
Fox, Class B (1)(2)  1,107,400  39,734 
Walt Disney (2)  262,209  29,113 
    68,847 
Interactive Media & Services 1.3%     
Facebook, Class A (1)(2)  1,837,530  306,298 
    306,298 
Media 0.3%     
Comcast, Class A  2,012,387  80,455 
    80,455 
Total Communication Services    1,112,722 
CONSUMER DISCRETIONARY 2.9%     
Hotels, Restaurants & Leisure 1.6%     
Las Vegas Sands  2,027,788  123,614 
McDonald's  1,315,251  249,766 
Wynn Resorts (2)  144,900  17,290 
    390,670 
Multiline Retail 1.0%     
Dollar Tree (1)(2)  2,336,800  245,457 
    245,457 
Specialty Retail 0.3%     
Ross Stores (2)  663,671  61,788 
    61,788 
Total Consumer Discretionary    697,915 
 
First Page Footer     

 


 

T. ROWE PRICE VALUE FUND

  Shares/Par  $ Value 
(Cost and value in $000s)     
CONSUMER STAPLES 6.9%     
Beverages 0.2%     
PepsiCo  391,300  47,954 
    47,954 
Food & Staples Retailing 0.5%     
Walmart (2)  1,401,214  136,660 
    136,660 
Food Products 4.7%     
Conagra Brands (2)  10,236,163  283,951 
Tyson Foods, Class A (2)  12,360,951  858,221 
    1,142,172 
Tobacco 1.5%     
Philip Morris International  4,077,114  360,376 
    360,376 
Total Consumer Staples    1,687,162 
ENERGY 8.5%     
Oil, Gas & Consumable Fuels 8.5%     
BP, ADR (2)  6,130,359  268,019 
Chevron (2)  1,528,900  188,330 
Concho Resources (2)  1,377,710  152,871 
ConocoPhillips  2,756,700  183,982 
EOG Resources (2)  1,226,812  116,768 
Occidental Petroleum  3,485,800  230,760 
Pioneer Natural Resources (2)  813,000  123,804 
TOTAL, ADR  8,313,033  462,620 
TransCanada  7,859,361  353,200 
Total Energy    2,080,354 
FINANCIALS 15.9%     
Banks 7.3%     
Bank of America  18,915,000  521,865 
Fifth Third Bancorp (2)  10,702,908  269,928 
First Republic Bank (2)  447,702  44,976 
JPMorgan Chase (2)  2,304,211  233,255 
     

 


 

T. ROWE PRICE VALUE FUND

  Shares/Par  $ Value 
(Cost and value in $000s)     
 
PNC Financial Services Group  1,548,493  189,938 
Wells Fargo (2)  10,686,033  516,349 
    1,776,311 
Capital Markets 3.1%     
Ameriprise Financial (2)  771,082  98,776 
Charles Schwab (2)  6,154,626  263,172 
Intercontinental Exchange (2)  3,500,270  266,510 
Morgan Stanley (2)  2,789,851  117,732 
    746,190 
Insurance 5.5%     
American International Group (2)  8,137,937  350,419 
Chubb (2)  2,494,054  349,367 
Marsh & McLennan (2)  2,809,520  263,814 
Prudential Financial (2)  1,455,900  133,768 
Willis Towers Watson (2)  1,411,623  247,952 
    1,345,320 
Total Financials    3,867,821 
HEALTH CARE 19.3%     
 
Health Care Equipment & Supplies 7.3%     
Becton Dickinson & Company (2)  1,427,777  356,559 
Boston Scientific (1)(2)  4,523,100  173,597 
Cooper (2)  38,500  11,403 
Danaher (2)  3,598,828  475,117 
Hologic (1)(2)  586,871  28,405 
Medtronic (2)  3,847,137  350,397 
Stryker (2)  1,086,100  214,526 
Teleflex  80,200  24,233 
Zimmer Biomet Holdings (2)  1,134,700  144,901 
    1,779,138 
Health Care Providers & Services 2.9%     
Anthem (2)  615,504  176,637 
Cigna  1,749,479  281,351 
CVS Health  4,531,800  244,400 
    702,388 
     

 


 

T. ROWE PRICE VALUE FUND

 
 
 
  Shares/Par  $ Value 
(Cost and value in $000s)     
 
Life Sciences Tools & Services 2.5%     
Agilent Technologies  1,283,407  103,160 
Thermo Fisher Scientific  1,829,990  500,905 
    604,065 
Pharmaceuticals 6.6%     
Elanco Animal Health (1)(2)  4,131,753  132,505 
Eli Lilly  1,555,865  201,889 
Merck  5,906,180  491,217 
Pfizer  18,316,066  777,884 
    1,603,495 
Total Health Care    4,689,086 
INDUSTRIALS & BUSINESS SERVICES 8.4%     
Aerospace & Defense 3.6%     
Boeing  1,201,922  458,437 
Northrop Grumman (2)  989,063  266,651 
Spirit AeroSystems Holdings, Class A  1,713,500  156,837 
    881,925 
Commercial Services & Supplies 0.5%     
Republic Services (2)  1,535,833  123,450 
    123,450 
Industrial Conglomerates 3.3%     
GE (2)  44,922,300  448,774 
Honeywell International (2)  1,636,779  260,117 
Roper Technologies (2)  235,088  80,393 
    789,284 
Machinery 0.5%     
Fortive (2)  1,068,695  89,653 
PACCAR (2)  520,978  35,499 
    125,152 
Professional Services 0.5%     
Nielsen Holdings (2)  5,264,049  124,600 
    124,600 
Total Industrials & Business Services    2,044,411 
     

 


 

T. ROWE PRICE VALUE FUND

 
 
 
  Shares/Par  $ Value 
(Cost and value in $000s)     
INFORMATION TECHNOLOGY 16.0%     
Communications Equipment 3.4%     
Cisco Systems (2)  13,326,969  719,523 
Motorola Solutions  827,700  116,226 
    835,749 
Electronic Equipment, Instruments & Components 1.6%     
Corning  4,010,526  132,748 
Keysight Technologies (1)  2,919,048  254,541 
    387,289 
IT Services 0.3%     
Fidelity National Information Services (2)  563,700  63,754 
    63,754 
Semiconductors & Semiconductor Equipment 4.6%     
Analog Devices  343,800  36,192 
ASML Holding (2)  549,400  103,315 
Broadcom (2)  895,566  269,305 
Micron Technology (1)(2)  4,101,300  169,507 
NVIDIA (2)  777,600  139,626 
NXP Semiconductors  1,583,585  139,973 
QUALCOMM  2,065,980  117,823 
Texas Instruments (2)  1,284,977  136,297 
    1,112,038 
Software 6.1%     
Microsoft (2)  10,083,500  1,189,248 
Synopsys (1)(2)  2,540,838  292,578 
    1,481,826 
Total Information Technology    3,880,656 
MATERIALS 3.4%     
Chemicals 1.7%     
Air Products & Chemicals  961,900  183,684 
DowDuPont (2)  3,443,627  183,580 
Linde  311,237  54,756 
    422,020 
     

 


 

T. ROWE PRICE VALUE FUND

  Shares/Par  $ Value 
(Cost and value in $000s)     
 
Containers & Packaging 1.7%     
Ball (2)  3,144,800  181,958 
International Paper (2)  2,443,131  113,044 
Packaging Corp. of America (2)  1,140,800  113,373 
    408,375 
Total Materials    830,395 
REAL ESTATE 3.0%     
Equity Real Estate Investment Trusts 3.0%     
Crown Castle International, REIT (2)  828,561  106,056 
Prologis, REIT (2)  3,421,700  246,191 
Public Storage, REIT (2)  776,500  169,106 
Ventas, REIT (2)  1,505,200  96,047 
Weyerhaeuser, REIT (2)  4,241,500  111,721 
Total Real Estate    729,121 
UTILITIES 9.4%     
Electric Utilities 6.7%     
Duke Energy (2)  2,274,761  204,729 
Entergy (2)  3,844,180  367,619 
Evergy  2,827,928  164,161 
NextEra Energy (2)  2,992,233  578,458 
Southern (2)  6,237,322  322,345 
    1,637,312 
Multi-Utilities 2.7%     
NiSource (2)  5,578,271  159,873 
Sempra Energy (2)  3,851,571  484,759 
    644,632 
Total Utilities    2,281,944 
Total Common Stocks (Cost $20,330,950)    23,901,587 
 
 
 
 
     

 


 

T. ROWE PRICE VALUE FUND

 
 
 
  Shares/Par  $ Value 
(Cost and value in $000s)     
CONVERTIBLE PREFERRED STOCKS 1.1%     
HEALTH CARE 0.2%     
Health Care Equipment & Supplies 0.2%     
Becton Dickinson & Company, Series A, 6.125%, 5/1/20 (2)  845,372  52,604 
Total Health Care    52,604 
INDUSTRIALS & BUSINESS SERVICES 0.2%     
Machinery 0.2%     
Fortive, Series A, 5.00%, 7/1/21  37,574  39,456 
Total Industrials & Business Services    39,456 
UTILITIES 0.7%     
Electric Utilities 0.4%     
NextEra Energy, 6.123%, 9/1/19 (2)  1,649,148  102,620 
    102,620 
Multi-Utilities 0.3%     
Sempra Energy, Series A, 6.00%, 1/15/21  465,537  49,290 
Sempra Energy, Series B, 6.75%, 7/15/21  243,553  25,892 
    75,182 
Total Utilities    177,802 
Total Convertible Preferred Stocks (Cost $232,958)    269,862 
 
CORPORATE BONDS 0.1%     
Pacific Gas & Electric, 3.95%, 12/1/47 (1)(3)  18,528,000  14,915 
Pacific Gas & Electric, 4.00%, 12/1/46 (1)(3)  7,969,000  6,425 
Total Corporate Bonds (Cost $20,226)    21,340 
 
SHORT-TERM INVESTMENTS 0.9%     
Money Market Funds 0.9%     
T. Rowe Price Government Reserve Fund, 2.49% (4)(5)  216,498,672  216,499 
Total Short-Term Investments (Cost $216,499)    216,499 
 
 
     

 


 

T. ROWE PRICE VALUE FUND

  Shares/Par    $ Value 
(Cost and value in $000s)       
SECURITIES LENDING COLLATERAL 3.7%       
Investments in a Pooled Account through Securities Lending       
Program with State Street Bank and Trust Company 3.7%       
Short-Term Funds 3.7%       
T. Rowe Price Short-Term Fund, 2.60% (4)(5)  89,095,892    890,959 
Total Investments in a Pooled Account through Securities Lending Program with     
State Street Bank and Trust Company      890,959 
Total Securities Lending Collateral (Cost $890,959)      890,959 
 
Total Investments in Securities 104.1%       
(Cost $21,691,592)    $  25,300,247 
Other Assets Less Liabilities (4.1)%      (991,400) 
Net Assets 100.0%    $  24,308,847 

 

Shares/Par are denominated in U.S. dollars unless otherwise noted.
(1) Non-income producing
(2) All or a portion of this security is on loan at March 31, 2019.
(3) Issuer is currently in a Chapter 11 bankruptcy reorganization proceeding; the
amount and timing of future distributions is uncertain.
(4) Affiliated Companies
(5) Seven-day yield

ADR

REIT

American Depositary Receipts

A domestic Real Estate Investment Trust whose distributions pass-through with original tax character to the shareholder

 


 

T. ROWE PRICE VALUE FUND

Affiliated Companies
($000s)

The fund may invest in certain securities that are considered affiliated companies. As defined
by the 1940 Act, an affiliated company is one in which the fund owns 5% or more of the
outstanding voting securities, or a company that is under common ownership or control. The
following securities were considered affiliated companies for all or some portion of the three
months ended March 31, 2019. Net realized gain (loss), investment income, change in net
unrealized gain/loss, and purchase and sales cost reflect all activity for the period then ended.

        Change in Net     
    Net Realized Gain    Unrealized    Investment 
Affiliate      (Loss)    Gain/Loss    Income 
T. Rowe Price Government             
Reserve Fund    $    $    $  593 
T. Rowe Price Short-Term Fund            —++ 
Totals    $  —#  $    $  593+ 
 
 
Supplementary Investment Schedule           
    Value  Purchase  Sales    Value 
Affiliate    12/31/18  Cost  Cost    3/31/19 
T. Rowe Price Government             
Reserve Fund  $  237,775    ¤  ¤ $    216,499 
T. Rowe Price Short-Term             
Fund    510,588    ¤  ¤    890,959 
          $    1,107,458^ 

 

# Capital gain distributions from mutual funds represented $0 of the net realized gain (loss).
++ Excludes earnings on securities lending collateral, which are subject to rebates and fees.
+ Investment income comprised $593 of dividend income and $0 of interest income.
¤ Purchase and sale information not shown for cash management funds.
^ The cost basis of investments in affiliated companies was $1,107,458.

The accompanying notes are an integral part of this Portfolio of Investments.


 

T. ROWE PRICE VALUE FUND
Unaudited

NOTES TO PORTFOLIO OF
INVESTMENTS

T. Rowe Price Value Fund, Inc. (the fund) is registered under the Investment Company Act of 1940 (the 1940 Act) as an
open-end management investment company and follows accounting and reporting guidance of the Financial Accounting
Standards Board Accounting Standards Codification Topic 946. The accompanying Portfolio of Investments was prepared
in accordance with accounting principles generally accepted in the United States of America (GAAP). For additional
information on the fund’s significant accounting policies and investment related disclosures, please refer to the fund’s most
recent semiannual or annual shareholder report and its prospectus.

VALUATION

The fund’s financial instruments are valued at the close of the New York Stock Exchange (NYSE), normally 4 p.m. ET,
each day the NYSE is open for business.

Fair Value
The fund’s financial instruments are reported at fair value, which GAAP defines as the price that would be received to
sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. The T. Rowe Price Valuation Committee (the Valuation Committee) is an internal committee that has been
delegated certain responsibilities by the fund’s Board of Directors (the Board) to ensure that financial instruments are
appropriately priced at fair value in accordance with GAAP and the 1940 Act. Subject to oversight by the Board, the
Valuation Committee develops and oversees pricing-related policies and procedures and approves all fair value
determinations. Specifically, the Valuation Committee establishes procedures to value securities; determines pricing
techniques, sources, and persons eligible to effect fair value pricing actions; oversees the selection, services, and
performance of pricing vendors; oversees valuation-related business continuity practices; and provides guidance on
internal controls and valuation-related matters. The Valuation Committee reports to the Board and has representation
from legal, portfolio management and trading, operations, risk management, and the fund’s treasurer.

Various valuation techniques and inputs are used to determine the fair value of financial instruments. GAAP
establishes the following fair value hierarchy that categorizes the inputs used to measure fair value:

Level 1 - quoted prices (unadjusted) in active markets for identical financial instruments that the fund can access at
the reporting date

Level 2 - inputs other than Level 1 quoted prices that are observable, either directly or indirectly (including, but not
limited to, quoted prices for similar financial instruments in active markets, quoted prices for identical or
similar financial instruments in inactive markets, interest rates and yield curves, implied volatilities, and
credit spreads)

Level 3 - unobservable inputs

Observable inputs are developed using market data, such as publicly available information about actual events or
transactions, and reflect the assumptions that market participants would use to price the financial instrument.
Unobservable inputs are those for which market data are not available and are developed using the best information
available about the assumptions that market participants would use to price the financial instrument. GAAP requires
valuation techniques to maximize the use of relevant observable inputs and minimize the use of unobservable inputs.
When multiple inputs are used to derive fair value, the financial instrument is assigned to the level within the fair value
hierarchy based on the lowest-level input that is significant to the fair value of the financial instrument. Input levels are
not necessarily an indication of the risk or liquidity associated with financial instruments at that level but rather the
degree of judgment used in determining those values.

Valuation Techniques
Equity securities listed or regularly traded on a securities exchange or in the over-the-counter (OTC) market are valued
at the last quoted sale price or, for certain markets, the official closing price at the time the valuations are made. OTC
Bulletin Board securities are valued at the mean of the closing bid and asked prices. A security that is listed or traded on


 

T. ROWE PRICE VALUE FUND

more than one exchange is valued at the quotation on the exchange determined to be the primary market for such
security. Listed securities not traded on a particular day are valued at the mean of the closing bid and asked prices.
Actively traded equity securities listed on a domestic exchange generally are categorized in Level 1 of the fair value
hierarchy. OTC Bulletin Board securities, certain preferred securities, and equity securities traded in inactive markets
generally are categorized in Level 2 of the fair value hierarchy.

Debt securities generally are traded in the OTC market and are valued at prices furnished by dealers who make markets in
such securities or by an independent pricing service, which considers the yield or price of bonds of comparable quality,
coupon, maturity, and type, as well as prices quoted by dealers who make markets in such securities. Generally, debt
securities are categorized in Level 2 of the fair value hierarchy; however, to the extent the valuations include significant
unobservable inputs, the securities would be categorized in Level 3.

Investments in mutual funds are valued at the mutual fund’s closing NAV per share on the day of valuation and are
categorized in Level 1 of the fair value hierarchy.

Thinly traded financial instruments and those for which the above valuation procedures are inappropriate or are
deemed not to reflect fair value are stated at fair value as determined in good faith by the Valuation Committee. The
objective of any fair value pricing determination is to arrive at a price that could reasonably be expected from a current
sale. Financial instruments fair valued by the Valuation Committee are primarily private placements, restricted
securities, warrants, rights, and other securities that are not publicly traded.

Subject to oversight by the Board, the Valuation Committee regularly makes good faith judgments to establish and
adjust the fair valuations of certain securities as events occur and circumstances warrant. For instance, in determining
the fair value of an equity investment with limited market activity, such as a private placement or a thinly traded public
company stock, the Valuation Committee considers a variety of factors, which may include, but are not limited to, the
issuer’s business prospects, its financial standing and performance, recent investment transactions in the issuer, new
rounds of financing, negotiated transactions of significant size between other investors in the company, relevant market
valuations of peer companies, strategic events affecting the company, market liquidity for the issuer, and general
economic conditions and events. In consultation with the investment and pricing teams, the Valuation Committee will
determine an appropriate valuation technique based on available information, which may include both observable and
unobservable inputs. The Valuation Committee typically will afford greatest weight to actual prices in arm’s length
transactions, to the extent they represent orderly transactions between market participants; transaction information can
be reliably obtained; and prices are deemed representative of fair value. However, the Valuation Committee may also
consider other valuation methods such as market-based valuation multiples; a discount or premium from market value
of a similar, freely traded security of the same issuer; or some combination. Fair value determinations are reviewed on a
regular basis and updated as information becomes available, including actual purchase and sale transactions of the
issue. Because any fair value determination involves a significant amount of judgment, there is a degree of subjectivity
inherent in such pricing decisions, and fair value prices determined by the Valuation Committee could differ from
those of other market participants. Depending on the relative significance of unobservable inputs, including the
valuation technique(s) used, fair valued securities may be categorized in Level 2 or 3 of the fair value hierarchy.


 

T. ROWE PRICE VALUE FUND

Valuation Inputs
The following table summarizes the fund’s financial instruments, based on the inputs used to determine their fair values
on March 31, 2019 (for further detail by category, please refer to the accompanying Portfolio of Investments):

($000s)    Level 1  Level 2  Level 3  Total Value 
Assets           
Common Stocks  $  23,901,587$  — $  — $  23,901,587 
Convertible Preferred Stocks      269,862    269,862 
Fixed Income Securities1      21,340    21,340 
Short-Term Investments    216,499      216,499 
Securities Lending Collateral    890,959      890,959 
Total  $  25,009,045$  291,202$  — $  25,300,247 

 

1 Includes Corporate Bonds.